{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:59:04Z","timestamp":1768546744591,"version":"3.49.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011696","name":"Shahed University","doi-asserted-by":"publisher","award":["967586001"],"award-info":[{"award-number":["967586001"]}],"id":[{"id":"10.13039\/501100011696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.intimp.2020.107054","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T17:48:57Z","timestamp":1602611337000},"page":"107054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PB","title":["Protective effects of egg yolk immunoglobulins (IgYs) developed against recombinant immunogens CtxB, OmpW and TcpA on infant mice infected with Vibrio cholerae"],"prefix":"10.1016","volume":"89","author":[{"given":"Fatemeh","family":"Taheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tooba Sadat","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Latif Mousavi","family":"Gargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.107054_b0005","unstructured":"(WHO) WHO, Cholera 2017. Weekly Epidemiological Record (WER) 93 (2018) 12."},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/IAI.01139-08","article-title":"Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera","volume":"77","author":"Schild","year":"2009","journal-title":"IAI"},{"issue":"10","key":"10.1016\/j.intimp.2020.107054_b0015","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1128\/IAI.00398-10","article-title":"Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility","volume":"78","author":"Bishop","year":"2010","journal-title":"IAI"},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/CMR.8.1.48","article-title":"Cholera","volume":"8","author":"Kaper","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2020.107054_b0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/MMBR.62.4.1301-1314.1998","article-title":"Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae","volume":"62","author":"Faruque","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"5270","key":"10.1016\/j.intimp.2020.107054_b0030","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1126\/science.272.5270.1910","article-title":"Lysogenic conversion by a filamentous phage encoding cholera toxin","volume":"272","author":"Waldor","year":"1996","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/09687680410001663267","article-title":"Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms","volume":"21","author":"Haan","year":"2004","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.intimp.2020.107054_b0040","series-title":"Vibrio cholerae: genomics and molecular biology","author":"Faruque","year":"2008"},{"issue":"9","key":"10.1016\/j.intimp.2020.107054_b0045","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1073\/pnas.84.9.2833","article-title":"Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.","volume":"84","author":"Taylor","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5295","key":"10.1016\/j.intimp.2020.107054_b0050","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1126\/science.274.5295.2025","article-title":"Global climate and infectious disease: the cholera paradigm","volume":"274","author":"Colwell","year":"1996","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/IAI.02617-14","article-title":"Host intestinal signal-promoted biofilm dispersal induces Vibrio cholerae colonization","volume":"83","author":"Hay","year":"2015","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00294-015-0532-8","article-title":"Parallel quorum sensing signaling pathways in Vibrio cholerae","volume":"62","author":"Jung","year":"2016","journal-title":"Curr. Genet"},{"issue":"9","key":"10.1016\/j.intimp.2020.107054_b0065","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/AAC.46.9.2948-2955.2002","article-title":"Occurrence of antibiotic resistance gene cassettes aac(6\u2032)-Ib, dfrA5, dfrA12, and ereA2 in Class I integrons in Non-O1, Non-O139 Vibrio cholerae strains in India","volume":"46","author":"Thungapathra","year":"2002","journal-title":"AAC"},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/IAI.00982-12","article-title":"Novel cholix toxin variants, ADP-ribosylating toxins in Vibrio cholerae Non-O1\/Non-O139 strains, and their pathogenicity","volume":"81","author":"Awasthi","year":"2013","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.intimp.2020.107054_b0075","doi-asserted-by":"crossref","first-page":"722","DOI":"10.26719\/2011.17.8.722","article-title":"Two cases of Vibrio cholerae non-O1\/non-O139 septicaemia with favourable outcome in Lebanon","volume":"17","author":"Feghali","year":"2011","journal-title":"East Mediterr Health J."},{"issue":"9","key":"10.1016\/j.intimp.2020.107054_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106731","article-title":"Outer membrane vesicles mediate transport of biologically active Vibrio cholerae cytolysin (VCC) from V. cholerae strains","volume":"9","author":"Elluri","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.vaccine.2017.09.004","article-title":"Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions","volume":"36","author":"Adriani","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/iai.44.2.439-444.1984","article-title":"Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae","volume":"44","author":"Sears","year":"1984","journal-title":"Infection and Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1110\/ps.29402","article-title":"Toward genomic identification of \u03b2-barrel membrane proteins: composition and architecture of known structures","volume":"11","author":"Wimley","year":"2002","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.micro.61.080706.093245","article-title":"Biogenesis of the gram-negative bacterial outer membrane","volume":"61","author":"Bos","year":"2007","journal-title":"Annu. Rev. Microbiol."},{"issue":"5604","key":"10.1016\/j.intimp.2020.107054_b0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.1078973","article-title":"Role of a highly conserved bacterial protein in outer membrane protein assembly","volume":"299","author":"Voulhoux","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0005-2736(02)00577-1","article-title":"The structure of bacterial outer membrane proteins","volume":"1565","author":"Schulz","year":"2002","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"3","key":"10.1016\/j.intimp.2020.107054_b0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1107\/S1744309105005014","article-title":"Expression, purification, crystallization and preliminary X-ray studies of the outer membrane efflux proteins OprM and OprN from Pseudomonas aeruginosa","volume":"61","author":"Broutin","year":"2005","journal-title":"Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.intimp.2020.107054_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00158","article-title":"Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate","volume":"7","author":"Singh","year":"2016","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.intimp.2020.107054_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077631","article-title":"Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii","volume":"8","author":"Moriel","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.intimp.2020.107054_b0130","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/21645515.2015.1010910","article-title":"Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology","volume":"11","author":"Chiang","year":"2015","journal-title":"Human Vaccines Immunotherapeutics"},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0135","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1128\/AEM.68.2.881-892.2002","article-title":"Transcriptional and proteomic analysis of a ferric uptake regulator (fur) mutant of Shewanella oneidensis: possible involvement of fur in energy metabolism, transcriptional regulation, and oxidative stress","volume":"68","author":"Thompson","year":"2002","journal-title":"Appl. Environ. Microbiol."},{"issue":"11","key":"10.1016\/j.intimp.2020.107054_b0140","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1074\/jbc.M512365200","article-title":"The outer membrane protein OmpW forms an eight-stranded \u03b2-barrel with a hydrophobic channel","volume":"281","author":"Hong","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2020.107054_b0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.resmic.2007.05.004","article-title":"The ompW (porin) gene mediates methyl viologen (paraquat) efflux in Salmonella enterica serovar Typhimurium","volume":"158","author":"Gil","year":"2007","journal-title":"Res. Microbiol."},{"issue":"6364","key":"10.1016\/j.intimp.2020.107054_b0150","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.aad5901","article-title":"Genomic history of the seventh pandemic of cholera in Africa","volume":"358","author":"Weill","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4099-8","article-title":"Mapping tuberculosis treatment outcomes in Ethiopia","volume":"19","author":"Alene","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.intimp.2020.107054_b0160","doi-asserted-by":"crossref","first-page":"A83","DOI":"10.1016\/j.vaccine.2019.06.031","article-title":"Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms","volume":"38","author":"Das","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2020.107054_b0165","first-page":"2","article-title":"Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam","volume":"80","author":"Trach","year":"2002","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0264-410X(92)90030-N","article-title":"Safety and immunogenicity of an oral recombinant cholera B subunit\u2014whole cell vaccine in Swedish volunteers","volume":"10","author":"Jertborn","year":"1992","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.intimp.2020.107054_b0175","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0264-410X(93)90125-H","article-title":"Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers","volume":"11","author":"Jertborn","year":"1993","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.intimp.2020.107054_b0180","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.intimp.2020.107054_b0185","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2003.12.033","article-title":"Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR","volume":"22","author":"Viret","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0190","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol."},{"key":"10.1016\/j.intimp.2020.107054_b0195","series-title":"Bioactive Egg Compounds","year":"2007"},{"issue":"31","key":"10.1016\/j.intimp.2020.107054_b0200","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1016\/j.vaccine.2012.04.091","article-title":"Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients","volume":"30","author":"Rahman","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2020.107054_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010152","article-title":"Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice","volume":"5","author":"Nguyen","year":"2010","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.intimp.2020.107054_b0210","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/CVI.05075-11","article-title":"Cross-protection of chicken immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in mice","volume":"18","author":"Wallach","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107054_b0215","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ppul.20875","article-title":"Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients","volume":"43","author":"Nilsson","year":"2008","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.intimp.2020.107054_b0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14573\/altex.2004.suppl.3","article-title":"Alternatives to animal experimentation in basic research","volume":"21","author":"Gruber","year":"2004","journal-title":"Altex."},{"issue":"3","key":"10.1016\/j.intimp.2020.107054_b0225","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/2000-1967-145","article-title":"Avian antibodies can eliminate interference due to complement activation in ELISA","volume":"106","author":"Carlander","year":"2001","journal-title":"Upsala J. Med. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2020.107054_b0230","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.2007.08388.x","article-title":"Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice","volume":"158","author":"Sesarman","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.intimp.2020.107054_b0235","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0167-5699(95)80008-5","article-title":"IgY: clues to the origins of modern antibodies","volume":"16","author":"Warr","year":"1995","journal-title":"Immunol. Today"},{"issue":"3","key":"10.1016\/j.intimp.2020.107054_b0240","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1095-6433(01)00508-6","article-title":"Generation and application of chicken egg-yolk antibodies","volume":"131","author":"Tini","year":"2002","journal-title":"Comp. Biochem. Physiol. A: Mol. Integr. Physiol."},{"issue":"8","key":"10.1016\/j.intimp.2020.107054_b0245","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1096\/fasebj.4.8.1970792","article-title":"Efficient production of chicken egg yolk antibodies against a conserved mammalian protein","volume":"4","author":"Gassmann","year":"1990","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.intimp.2020.107054_b0250","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3382\/ps.0722361","article-title":"Research note: avidity of chicken yolk antibodies to enterotoxigenic Escherichia coli fimbriae","volume":"72","author":"Ikemori","year":"1993","journal-title":"Poultry Sci."},{"issue":"3","key":"10.1016\/j.intimp.2020.107054_b0255","first-page":"207","article-title":"Designing and expression of recombinant chimeric protein containing CtxB and OmpW from Vibrio Cholerae and evaluation of its immunogenicity","volume":"15","author":"Vakili","year":"2018","journal-title":"Iranian J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107054_b0260","first-page":"33","article-title":"Expression and purification of recombinant chimeric protein contains CtxB and TcpA from Vibrio cholera and investigation of antibody titer in mouse","volume":"20","author":"Amerian","year":"2017","journal-title":"Pathobiol. Res."},{"issue":"1-2","key":"10.1016\/j.intimp.2020.107054_b0265","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vetimm.2015.02.012","article-title":"Improving adjuvant systems for polyclonal egg yolk antibody (IgY) production in laying hens in terms of productivity and animal welfare","volume":"165","author":"Marcq","year":"2015","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.intimp.2020.107054_b0270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1452-3981(23)14006-5","article-title":"Optimized protocol of chicken antibody (IgY) purification providing electrophoretically homogenous preparations","volume":"8","author":"Hodek","year":"2013","journal-title":"Int. J. Electrochem. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2020.107054_b0275","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1128\/IAI.72.12.7012-7021.2004","article-title":"Oral vaccination of BALB\/c mice with salmonella enterica serovar typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model","volume":"72","author":"DiGiandomenico","year":"2004","journal-title":"IAI"},{"key":"10.1016\/j.intimp.2020.107054_b0280","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.aquaculture.2018.10.045","article-title":"Immunoglobulin Y in the diagnosis of Aeromonas hydrophila infection in Nile tilapia (Oreochromis niloticus)","volume":"500","author":"Fernandes","year":"2019","journal-title":"Aquaculture"},{"issue":"12","key":"10.1016\/j.intimp.2020.107054_b0285","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1128\/jcm.25.12.2314-2316.1987","article-title":"Large production of cholera toxin by Vibrio cholerae O1 in yeast extract peptone water","volume":"25","author":"Iwanaga","year":"1987","journal-title":"J Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107054_b0290","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2005.01.050","article-title":"Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea","volume":"128","author":"Paton","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.intimp.2020.107054_b0295","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/73111","article-title":"A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans","volume":"6","author":"Paton","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.107054_b0300","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.meegid.2018.03.001","article-title":"The role of TonB-dependent copper receptor in virulence of Acinetobacter baumannii","volume":"60","author":"Abdollahi","year":"2018","journal-title":"Infection, Genetics Evol."},{"issue":"11-12","key":"10.1016\/j.intimp.2020.107054_b0305","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/psc.2930","article-title":"Development of lipopolysaccharide-mimicking peptides and their immunoprotectivity against Vibrio cholerae serogroup O1 : LPS mimicking peptides against V . cholera","volume":"22","author":"Mohammad Pour Ghazi","year":"2016","journal-title":"J. Pept. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2020.107054_b0310","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2105\/AJPH.94.11.1926","article-title":"A global perspective on vaccine safety and public health: The Global Advisory Committee on Vaccine Safety","volume":"94","author":"Folb","year":"2004","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.intimp.2020.107054_b0315","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1073\/pnas.75.6.2669","article-title":"Mechanism of cholera toxin action: Covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system","volume":"75","author":"Cassel","year":"1978","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2020.107054_b0320","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1365-2672.2009.04296.x","article-title":"Cloning and expression of an outer membrane protein OmpW of Aeromonas hydrophila and study of its distribution in Aeromonas spp","volume":"107","author":"Maiti","year":"2009","journal-title":"J. Appl. Microbiol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0325","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11274-007-9463-y","article-title":"Expression and purification of two major outer membrane proteins from Vibrio alginolyticus","volume":"24","author":"Qian","year":"2008","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"3-4","key":"10.1016\/j.intimp.2020.107054_b0330","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.vetimm.2012.07.013","article-title":"Evaluation of two outer membrane proteins, Aha1 and OmpW of Aeromonas hydrophila as vaccine candidate for common carp","volume":"149","author":"Maiti","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0335","first-page":"7","article-title":"Production and purification of polyclonal antibody against Cholera Toxin","volume":"17","author":"Nazarian","year":"2015","journal-title":"J. Babol University of Medical Sci."},{"issue":"2","key":"10.1016\/j.intimp.2020.107054_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057269","article-title":"Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera","volume":"8","author":"Price","year":"2013","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.intimp.2020.107054_b0345","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.vaccine.2015.02.014","article-title":"Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection","volume":"33","author":"Vishwakarma","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0350","first-page":"47","article-title":"Production of chicken egg yolk antibody (IgY) against recombinant cholera toxin B subunit and evaluation of its prophylaxis potency in mice","volume":"15","author":"Barati","year":"2018","journal-title":"Iranian J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107054_b0355","first-page":"163","article-title":"Passive oral immunization by egg yolk immunoglobulin (IgY) to Vibrio cholerae effectively prevents cholera","volume":"64","author":"Hirai","year":"2010","journal-title":"Acta Med. Okayama"},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0360","first-page":"84","article-title":"Anti- vibrio cholerae IgY antibody inhibits mortality in suckling mice model","volume":"110","author":"Akbari","year":"2018","journal-title":"J. Natl. Med. Assoc."},{"issue":"10","key":"10.1016\/j.intimp.2020.107054_b0365","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1128\/IAI.72.10.6050-6060.2004","article-title":"A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated Pilus structure","volume":"72","author":"Taylor","year":"2004","journal-title":"IAI"},{"issue":"9","key":"10.1016\/j.intimp.2020.107054_b0370","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/IAI.73.9.5654-5665.2005","article-title":"Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems","volume":"73","author":"Harakuni","year":"2005","journal-title":"IAI"},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0375","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1242\/dmm.003970","article-title":"Drosophila melanogaster as a model for human intestinal infection and pathology","volume":"4","author":"Apidianakis","year":"2011","journal-title":"Disease Models Mech."},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0380","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI115270","article-title":"Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.","volume":"88","author":"Quiding","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2020.107054_b0385","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2004.06.118","article-title":"Expression and characterization of cholera toxin B\u2014pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice","volume":"321","author":"Ar\u00eaas","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2020.107054_b0390","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ppul.10290","article-title":"Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study : Oral IgY to CF Patients","volume":"35","author":"Kollberg","year":"2003","journal-title":"Pediatr. Pulmonol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920321561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920321561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:25:41Z","timestamp":1761585941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920321561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":78,"alternative-id":["S1567576920321561"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107054","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of egg yolk immunoglobulins (IgYs) developed against recombinant immunogens CtxB, OmpW and TcpA on infant mice infected with Vibrio cholerae","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107054"}}